KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Tax Provisions (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Tax Provisions data on record, last reported at -$17.8 million in Q4 2025.

  • For Q4 2025, Tax Provisions fell 485.05% year-over-year to -$17.8 million; the TTM value through Dec 2025 reached $42.7 million, down 37.1%, while the annual FY2025 figure was $42.7 million, 37.1% down from the prior year.
  • Tax Provisions reached -$17.8 million in Q4 2025 per CRL's latest filing, down from $31.6 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $55.8 million in Q4 2022 and bottomed at -$17.8 million in Q4 2025.
  • Average Tax Provisions over 5 years is $21.2 million, with a median of $24.2 million recorded in 2021.
  • Peak YoY movement for Tax Provisions: skyrocketed 559.91% in 2022, then plummeted 485.05% in 2025.
  • A 5-year view of Tax Provisions shows it stood at $23.8 million in 2021, then surged by 134.37% to $55.8 million in 2022, then tumbled by 64.61% to $19.8 million in 2023, then plummeted by 115.41% to -$3.0 million in 2024, then tumbled by 485.05% to -$17.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were -$17.8 million in Q4 2025, $31.6 million in Q3 2025, and $18.7 million in Q2 2025.